MeiraGTx at Cell 2026
Nov 12–13, 2026 London, UK ~800 attendees Website
MeiraGTx takes part in 2 sessions at Cell 2026 in London. Its sessions centre on lab models that help gene therapies move from research into medicine. The standout topic is using human retinal organoids to develop gene therapies for the eye.
| Organization | Cell 2026 Attendance |
|---|---|
MeiraGTx New York, New York | |
Clinical-stage gene therapy company with in-house viral vector manufacturing and programmes in eye, salivary gland and neurological disease. | Talk Fri Nov 13 9:25am–9:50am Human retinal organoids in gene therapy development Stem cells, organoids and cell modelsCell and gene therapy Panel Fri Nov 13 11:40am–12:05pm From Model To Medicine: Fixing The Translation Gap Stem cells, organoids and cell models |
Instantly find 20 buyers from MeiraGTx
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by Cell 2026 or its organizers. Submit a correction